Inhibition of placenta growth factor (PIGF) medicated metastasis and/or angiogenesis

Details for Australian Patent Application No. 2006304418 (hide)

Owner Immunomedics, Inc. Center for Molecular Medicine and Immunology

Inventors Goldenberg, David M.; Chang, Chien Hsing

Agent Davies Collison Cave

Pub. Number AU-A-2006304418

PCT Pub. Number WO2007/047609

Priority 60/728,292 19.10.05 US

Filing date 16 October 2006

Wipo publication date 26 April 2007

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047609 Priority application(s): WO2007/047609

11 September 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Inhibition of placenta growth factor (PIGF) mediated metastasis and/or angiogenesis

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304421-Powered wheelchair having side access battery compartment

2006304416-Ocular therapy using Glucocorticoid Derivatives selectively penetrating posterior segment tissues